Emerging infections of the gastrointestinal tract

Best Practice and Research: Clinical Gastroenterology

Volumn 23, Issue 1, 2009, Pages 89-99

  Schlenker, Christine ^a   Surawicz, Christina M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Aeromonas hydrophila; Arcobacter; Campylobacter concisus; Clostridium difficile; Edwardsiella tarda; Helicobacter heilmanii; Laribacter hongkongensis; Plesiomonas shigelloides; Sapovirus; Shigatoxin Escherichia coli

Indexed keywords

AMPICILLIN; COTRIMOXAZOLE; GATIFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; PROTON PUMP INHIBITOR; VANCOMYCIN;

AEROMONAS; AEROMONAS HYDROPHILA; ANTIBIOTIC RESISTANCE; ARCOBACTER; ARTICLE; ASTROVIRUS; BACTERIAL VIRULENCE; BACTEROIDES FRAGILIS; CALICIVIRUS; CAMPYLOBACTER; CLOSTRIDIUM DIFFICILE; DIARRHEA; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDWARDSIELLA TARDA; EPIDEMIC; GASTROENTERITIS; GASTROINTESTINAL INFECTION; HELICOBACTER; HELICOBACTER HEILMANNII; HUMAN; KLEBSIELLA OXYTOCA; LISTERIA MONOCYTOGENES; MICROBIOLOGICAL EXAMINATION; MORBIDITY; MORTALITY; NOROVIRUS; PATHOGENESIS; PLESIOMONAS; PLESIOMONAS SHIGELLOIDES; SAPOVIRUS; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; SIMIAN VIRUS 40; STOMACH ACID; VIRAL GASTROENTERITIS;

COMMUNICABLE DISEASES, EMERGING; DIARRHEA; GASTROENTERITIS; HUMANS; PROTON PUMP INHIBITORS; RISK FACTORS;

EID: 60949101045     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2008.11.014     Document Type: Article

References (90)

1. Hansman G.S., Oka T., Katayama K., et al. Human Sapoviruses: genetic diversity, recombination, and classification. Rev Med Virol 17 (2007) 133-141
2. Chiba S., Sakuma Y., Kogasaka R., et al. An outbreak of gastroenteritis associated with calicivirus in an infant home. J Med Virol 4 (1979) 249-254
3. Nguyen T.A., Hoang L., Pham L.D., et al. Norovirus and Sapovirus infections among children with acute gastroenteritis in Ho Chi Minh City during 2005-2006. J Trop Pediatr 54 (2008) 102-113
4. Phan T.G., Khamrin P., Quang T.D., et al. Emergence of intragenotype recombinant Sapovirus in Japan. Infect Genet Evol 7 (2007) 542-546
5. Svraka S., Duizer E., Vennema H., et al. Etiological role of viruses in outbreaks of acute gastroenteritis in the Netherlands from 1994 through 2005. J Clin Microbiol 45 (2007) 1389-1394
6. Ike A.C., Hartelt K., Oehme R.M., et al. Detection and characterization of Sapoviruses in outbreaks of gastroenteritis in southwest Germany. J Clin Virol 43 (2008) 37-41
7. Sdiri-Loulizi K., Gharbi-Khelifi H., de Rougemmong A., et al. Acute infantile gastroenteritis associated with human enteric viruses in Tunisia. J Clin Microbiol 46 (2008) 1349-1355
8. Gomes K.A., Stupka J.A., Gomez J., et al. Molecular characterization of calicivirus strains detected in outbreaks of gastroenteritis in Argentina. J Med Virol 79 (2007) 1703-1709
9. Dey S.K., Phan T.G., Nguyen T.A., et al. Prevalence of Sapovirus infection among infants and children with acute gastroenteritis in Dhaka City, Bangladesh during 2004-2005. J Med Virol 79 (2007) 633-638
10. Loo V.G., Poirier L., Miller M.A., et al. A predominately clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and high mortality. N Engl J Med 353 (2006) 2442-2449
11. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
12. Spigaglia P., and Mastrantonio P. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol 40 (2002) 3470-3475
13. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 (2005) 1079-1084
14. Nguyen G.C., Kaplan G.G., Harris M.L., et al. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 103 (2008) 1443-1450
15. Ananthakrishnan A.N., McGinley E.L., and Binion D.G. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 57 (2008) 150-152
16. Chernak E., Johnson C.C., Weltman A., et al. Severe Clostridium difficile-associated disease in populations previously at low risk - four states. MMWR Morb Mortal Wkly Rep 54 (2005) 1201-1205
17. Kuipers E.J., and Surawicz C.M. Clostridium difficile infection. Lancet 371 (2008) 1486-1488
18. Geaugerie L., Metz M., Barbut F., et al. Klebsiella oxytoca as an angent of antibiotic-associated hemorrhagic colitis. Clin Gastroenterol Hepatol 1 (2003) 370-376
19. Hogenauer C., Langner C., Beubler E., et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med 355 (2006) 2418-2426
20. Song H.J., Shim K.N., Jung S.A., et al. Antibiotic-associated diarrhea: candidate organisms other than Clostridium difficile. Korean J Intern Med 23 (2008) 9-15
21. Myers L.I., Firehamer B.D., Shoop D.S., et al. Bacteroides fragilis: a possible cause of acute diarrheal disease in newborn lambs. Infect Immun 44 (1984) 241-244
22. Myers L.I., and Shoop D.S. Association of enterotoxigenic Bacteroides fragilis with diarrheal disease in young pigs. Am J Vet Res 48 (1987) 774-775
23. Sack R.B., Myers L.I., Almeido-Hill J., et al. Enterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogen. J Diarrhoeal Dis Res 10 (1992) 4-9
24. Sack R.B., Albert M.J., Alam K., et al. Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study. J Clin Microbiol 32 (1994) 960-963
25. Pathela P., Hansan K.Z., Roy E., et al. Enterotoxigenic Bacteroides fragilis-associated diarrhea in children 0-2 years of age in rural Bangladesh. J Infect Dis 191 (2005) 1245-1252
26. Durmaz B., Dalgalar M., and Durmaz R. Prevalence of enterotoxigenic Bacteroides fragilis in patients with diarrhea: a controlled study. Anaerobe 11 (2005) 318-321
27. Cohen S.H., Shetab R., Tang-Feldman Y.J., et al. Prevalence of enterotoxigenic Bacteroides fragilis in hospital-acquired disease. Diagn Microbiol Infect Dis 55 (2006) 251-254
28. Pituch H., Obuch-Woszczatynski P., Luczak M., et al. Clostridium difficile and enterotoxigenic Bacteroides fragilis strains isolated from patients with antibiotic associated diarrhoea. Anaerobe 9 (2003) 161-163
29. Holton J. Enterotoxigenic Bacteroides fragilis. Curr Infect Dis Rep 10 (2008) 99-104
30. Sebald M., and Veron M. Teneru en bases de I'ADN et classification des vibrions. Ann Inst Pasteur (Paris) 105 (1963) 897-910
31. Butzler J.-P., Dekeyser P., Detrain M., et al. Related vibrio in stools. J Paediatr 82 (1973) 493-495
32. Goodwin C.S., Armstrong J.A., Chilvers T., et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Heliocobacter gen. nov. as Helicobacter pylori comb. Nov. and Helicobacter mustelae comb. Nov, respectively. Int J Syst Bacteriol 39 (1989) 397-405
33. Vandamme P., and De Ley J. Proposal for a new family, Campylobacteraceae. Int J Syst Bacteriol 41 (1991) 451-455
34. Vandamme P., Falsen E., Rossau R., et al. Revision of Campylobacter, Helicobacter, and Wolinella taxonomy: emendation of generic description and proposal of Arcobacter gen. Nov. Int J Syst Bacteriol 41 (1991) 88-103
35. Plenner J.L. The genus Campylobacter: a decade of progress. Clin Microbiol Rev 1 (1988) 157-172
36. On S.L.W. Taxonomy of Campylobacter, Arcobacter, Helicobacter and related bacteria: current status, future prospects and immediate concerns. J Appl Microbiol 90 (2001) 1S-15S
37. Engberg J., On S.L.W., Harrington C.S., et al. Prevalence of Campylobacter, Arcobacter, Helicobactera and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters. J Clin Microbiol 38 (2000) 286-291
38. Aabenhus R., Permin H., On S.L.W., et al. Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients. Scand J Infect Dis 34 (2002) 248-252
39. Engberg J., Bang D.D., Aabenhus R., et al. Campylobacter concisus: an evaluation of certain phenotypic and genotypic characteristics. Clin Microbiol Infect 11 (2005) 288-295
40. Fox J.G. The non-H. pylori helicobacters: their expanding roles in gastrointestinal and systemic diseases. Gut 50 (2002) 273-283
41. Stolte M., Kroher G., Meining A., et al. A comparison of H pyloris and H heilmannii gastritis. A matched control study involving 404 patients. Scand J Gastroenterol 32 (1997) 28-33
42. Heilmann K.L., and Borchard F. Gastritis due to spiral shaped bacteria other than H pylori: clinical, histological, and ultrastructural findings. Gut 32 (1991) 137-140
43. Ierardi E., Monno R.A., Gentile A., et al. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. J Clin Pathol 54 10 (2001) 774-777
44. Morgner A., Lehn N., Andersen L.P., et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 118 5 (2000) 821-828
45. Solnick J.V. Clinical significance of Helicobacter species other than Helicobacter pylori. Clin Infect Dis 36 (2003) 349-354
46. Apostolov E., Al-Soud W.A., Milsson I., et al. Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods. Scand J Gastroenterol 40 1 (2005) 96-102
47. Fox J.G., Dewhirst F.E., Shen Z., et al. Hepatic helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114 (1998) 755-763
48. Nilsson H.O., Taneera J., Castadel M., et al. Identification of Helicobacter pylori and other Helicobacter species by PCR hybridization, and partial DNA sequencing in human liver samples from patients with PSC or PBC. J Clin Microbiol 38 (2000) 1072-1076
49. Krasinskas A.M., Yao Y., Randhawa P., et al. Helicobacter pylori mayplay a contributory role in the pathogenesis of primary sclerosing cholangitis. Dig Dis Sci 52 9 (2007) 2265-2270
50. Abu Al-Soud W., Stenram U., Ljungh A., et al. DNA of Helicobacter spp. and common gut bacteria in primary liver carcinoma. Dig Liver Dis 40 2 (2008) 126-131
51. Huang Y., Fan X.G., Wang Z.M., et al. Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 57 12 (2004) 1273-1277
52. Fey P.D. Prevalence of non-0157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6 (2000) 430-533
53. Blanco J.E. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999. J Clin Microbiol 42 (2004) 311-319
54. Goldwater P.N. An outbreak of hemolytic uremic syndrome due to Escherichia coli 0157:H7: or was it?. Emerg Infect Dis 2 (1996) 153-154
55. Law D. Virulence factors of Escherichia coli 0157 and other Shiga toxin-producing E. coli. J Appl Microbiol 88 5 (2000) 729-745
56. Wells J.G., Shipman L.D., Greene K.D., et al. Isolation of E. coli serotype 0157:H7 and other Shiga-like toxin-producing E. coli from dairy cattle. J Clin Microbiol 29 5 (1991) 985-989
57. Mead P.S., and Griffin P.M. E. coli 0157:H7. Lancet 352 (1998) 1207-1212
58. Gerber A., Karch H., Allerberger F., et al. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-1000, in Germany and Austria: a prospective study. J Infect Dis 186 4 (2002) 493-500
59. Johnson K., Thrope C.M., and Sears C.L. The emerging clinical importance of non-0157 Shiga toxin-producing E. coli. Clin Infect Dis 43 (2006) 1587-1595
60. Houf K., Devriese L.A., Haesebrouck F., et al. Antimicrobial susceptibility patterns of Arcobacter butzleri and Arcobacter cryaerophilus strains isolated from humans and broilers. Microb Drug Resist 10 (2004) 243-247
61. Samie A., Obi C., Barrett L.J., et al. Prevalence of Campylobacter species, Helicobacter pylori and Arcobacter species in stool samples from the Venda region, Limpopo, South Africa: studies using molecular diagnostic methods. J Infect 54 (2007) 558-566
62. Vandenberg O., Houl K., Douat N., et al. Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium. J Antimicrob Chemother 57 (2006) 908-913
63. Newell D.G. Campylobacter concisus: an emerging pathogen?. Eur J Gastroenterol Hepatol 17 (2005) 1013-1014
64. Janda J.M., and Abbott S.L. Infections associated with the genus Edwardsiella: the role of Edwardsiella tarda in human disease. Clin Infect Dis 17 (1993) 742-748
65. Wilson J.P., Waterer R.R., Wofford Jr. J.D., et al. Serious infections with Edwardsiella tarda. A case report and review of the literature. Arch Intern Med 149 (1989) 208-210
66. Wang I.K., Kuo H.L., Chen Y.M., et al. Extraintestinal manifestations of Edwardsiella tarda infection. Int J Clin Pract 59 (2005) 917-921
67. Khan A.M., Faruque A.S.G., Houssain M.S., et al. Plesiomonas shigelloides-associated diarrhoea in Bangladeshi children: a hospital-based surveillance study. J Trop Pediatr 50 (2004) 354-356
68. Woo P.C., Lau S.K., and Yuen K.Y. Biliary tract disease as a risk factorfor Plesiomonas shigelloides bacteraemia: a nine-year experience in a Hong Kong hospital and review of the literature. New Microbiol 28 (2005) 45-55
69. Lautrop H. Aeromonas hydrophila isolated from human feces and its possible pathological significance. APMIS 144 (1961) 299-301
70. von Gravenitz A. The role of Aeromonas in diarrhea: a review. Infection 35 (2007) 57-64
71. Hofer E., dos Reis C.M.F., Theophilo G.N.D., et al. Aeromonas associated with acute diarrhea outbreak in Sao Bento do Una, Pernambuco. Rev Soc Bras Med Trop 39 (2006) 217-220
72. Kandakai-Olukemi Y.T., Mawak J.D., Olukemi M.A., et al. Aeromonas-related diarrhoea in Nasarawa, Nigeria. Ann Afr Med 6 (2007) 76-79
73. Subashkumar R., Thayumanavan T., Vivekanandham G., et al. Occurrence of Aeromonas hydrophila in acute gastroenteritis among children. Indian J Med Res 123 (2006) 61-66
74. Chan S.S.-W., and Ng K.C. Aeromonas spp. and infectious diarrhea, Hong Kong. Emerg Infect Dis (Letter) 10 (2004) 1406-1507
75. Chu Y.W., Wong C.H., Tsang G.K., et al. Lack of association between presentation of diarrhoeal symptoms and faecal isolation of Aeromonas spp. Amongst outpatients in Hong Kong. J Med Microbiol 55 (2006) 349-351
76. Figueras M.J., Horneman A.J., Martinez-Murcia A., et al. Controversial data on the association of Aeromonas with diarrhoea in a recent Hong Kong study. J Med Microbiol (2007) 996-997
77. Chan F.K., Ching J.Y., Ling T.K., et al. Aeromonas infection in acute suppurative cholangitis; review of 30 cases. J Infect 40 (2000) 69-73
78. Choi J.P., So L., Kwon H.H., et al. Clinical significance of spontaneous-aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study. Clin Infect Dis (2008)
79. Riedo F.X., Pinner R.W., Tosca M.I., et al. A point-source foodborne listeriosis outbreak: documented incubation period and possible mild illness. J Infect Dis 170 (1994) 693-696
80. Aureli P., Fiorucci G.C., Caroli D., et al. An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes. N Engl J Med 342 (2000) 1236-1241
81. Ooi S.T., and Lorber B. Gastroenteritis due to Listerial monocytogenes. Clin Infect Dis 40 (2005) 1327-1332
82. Yuen K.Y., Woo P.C., Teng J.L., et al. Laribacter hongkongensis nov. sp, nov, a novel gram-negative bateraemic from a cirrhotic patient with bactermia and empyaemic pus. J Clin Microbiol 39 (2001) 4222-4232
83. Woo P.C.Y., Kuhnert P., Burnens A.P., et al. Laribacter hongkongensis: a potential cause of infectious diarrhea. Diagn Microbiol Infect Dis 47 (2003) 551-556
84. Woo P.C.Y., Lau S.K.P., Teng J.L.L., et al. Association of Laribacter hongkongensis in community-acquired gastroenteritis with travel and eating fish: a multicentre case-control study. Lancet 363 (2004) 1941-1947
85. Farmer III J.J., Gangarosa R.E., and Gangarosa E.J. Does Laribactor hongkongensis cause diarrhoea, or does diarrhoea "cause" L. hongkongensis?. Lancet 363 (2004) 1923-1924
86. Howden C.W., and Hunt R.H. Relationship between gastric secretion and infection. Gut 28 (1987) 96-107
87. Leonard J., Marshall J.K., and Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol (2007) 1-10
88. Garcia Rodriguez L.A., Ruigómez A., and Panés J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol 5 12 (2007) 1418-1423
89. Jump R.L., Pultz J.M., and Donskey C.J. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea. Antimicrob Agents Chemother 51 (2007) 2883-2887
90. Cadle R., Mansouri M.D., Logan N., et al. Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm 64 (2007) 2359-2363